题名 | Therapeutic effects of Houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis |
作者 | |
发表日期 | 2019-02 |
发表期刊 | EXPERIMENTAL AND THERAPEUTIC MEDICINE 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | vernal keratoconjunctivitis houttuynia eye drops olopatadine hydrochloride eye drops efficacy |
其他关键词 | CONFOCAL MICROSCOPY ; PATHOGENESIS ; TACROLIMUS ; EFFICACY ; SAFETY |
摘要 | Therapeutic effects and safety of houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis (VK) were evaluated. A total of 926 patients with VK were collected in the Eye Hospital of Wenzhou Medical University from July 2011 to January 2017. Patients were divided into group A, B and C according to the use of different eye drops. Group A included 276 patients who were treated with houttuynia eye drops; group B included 305 patients who were treated with olopatadine hydrochloride eye drops; group C included 345 patients who were treated with houttuynia eye drops and olopatadine hydrochloride eye drops. Treatment was performed for 14 days. Eye symptoms before and after treatment, and at 1 h, 7 days and 14 days after drug administration were compared among groups to evaluate the therapeutic effect. At 1 h after drug administration, highest excellent rate was observed in group C, followed by group A, and good outcome rate was significantly higher in group C than in the other two groups (P<0.05), and effective rate was also significantly higher in group C than in the other two groups (P<0.05). At 7 days after treatment, excellent rate was significantly higher in group C than in the other two groups (P<0.05), and effective rate was higher in group C than in group B (P<0.05). At 14 days after treatment, excellent rate was significantly higher in group C than in the other two groups (P<0.05), while lowest good outcome rate and ineffective rate were found in group C, and no significant differences were found between group A and B (P>0.05). Houttuynia ophthalmic solution and olopatadine hydrochloride eye drops can both achieve good effect in the treatment of VK, and combined use of them can increase the efficacy and shorten treatment period. So, the combined treatment should be popularized. |
资助项目 | Wenzhou City Science and Technology Project (Wenzhou, China) [Y20160533] |
出版者 | SPANDIDOS PUBL LTD |
出版地 | ATHENS |
ISSN | 1792-0981 |
EISSN | 1792-1015 |
卷号 | 17期号:2页码:1224-1227 |
DOI | 10.3892/etm.2018.7079 |
页数 | 4 |
WOS类目 | Medicine, Research & Experimental |
WOS研究方向 | Research & Experimental Medicine |
WOS记录号 | WOS:000455641300034 |
收录类别 | SCIE ; PUBMED |
URL | 查看原文 |
PubMed ID | 30679995 |
PMC记录号 | PMC6327635 |
通讯作者地址 | [Xu, Xuegu]Wenzhou Med Univ, Eye Hosp, Dept Pharm, 270 Xueyuanxi Rd, Wenzhou 325003, Zhejiang, Peoples R China. |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/12819 |
专题 | 眼视光学院(生物医学工程学院)、附属眼视光医院_药剂科 |
通讯作者 | Xu, Xuegu |
作者单位 | Wenzhou Med Univ, Eye Hosp, Dept Pharm, 270 Xueyuanxi Rd, Wenzhou 325003, Zhejiang, Peoples R China |
第一作者单位 | 眼视光学院(生物医学工程学院)、附属眼视光医院_药剂科 |
通讯作者单位 | 眼视光学院(生物医学工程学院)、附属眼视光医院_药剂科 |
第一作者的第一单位 | 眼视光学院(生物医学工程学院)、附属眼视光医院_药剂科 |
推荐引用方式 GB/T 7714 | Xu, Xuegu,Cai, Yonghao. Therapeutic effects of Houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2019,17(2):1224-1227. |
APA | Xu, Xuegu, & Cai, Yonghao. (2019). Therapeutic effects of Houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 17(2), 1224-1227. |
MLA | Xu, Xuegu,et al."Therapeutic effects of Houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis".EXPERIMENTAL AND THERAPEUTIC MEDICINE 17.2(2019):1224-1227. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
查看访问统计 |
谷歌学术 |
谷歌学术中相似的文章 |
[Xu, Xuegu]的文章 |
[Cai, Yonghao]的文章 |
百度学术 |
百度学术中相似的文章 |
[Xu, Xuegu]的文章 |
[Cai, Yonghao]的文章 |
必应学术 |
必应学术中相似的文章 |
[Xu, Xuegu]的文章 |
[Cai, Yonghao]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论